Aldevron is a leading nucleic acid and protein biologic CDMO headquartered in North Dakota, and is part of the Danaher Corporation. Aldevron empowers drug developers globally with essential components in creating mRNA and pDNA-based vaccines and therapeutics. The company has extensive experience with nucleic acid–based therapies and has been delivering high-quality mRNA since 2017, manufacturing >80 GMP batches and supporting numerous IND submissions. Today, Aldevron provides mRNA–LNP drug product manufacturing and fill/finish from the discovery and preclinical stage all the way through clinical trials and commercialization.
